Supplementation with Pomanox pomegranate extract reduced the desire to eat compared to placebo.
Euromed (Mollet del Vallès, Spain) announced a recent study1 showing that its Pomanox pomegranate extract ingredient may help reduce food intake and boost satiety. The study was conducted at Queen Margaret University in Edinburgh. Euromed supplied the Pomanox supplements for the independent study.
In the three-week randomized, placebo-controlled trial, 28 male and female subjects between the ages of 18 and 65 were either given a placebo or an oral supplement of Euromed’s Pomanox containing 210 mg of punicalagin and 328 mg of total polyphenols. In the third week, satiety parameters were measured after both groups of participants consumed breakfast and lunch, which included a serving of pomegranate juice.
Using visual acuity scales (VAS) to record subjective sensations, the researchers measured participants’ hunger, desire to eat, fullness, and satisfaction levels. The researchers found that those taking the Pomanox extract experienced greater satisfaction and feelings of fullness compared to the placebo subjects. They concluded: “These findings suggest that consumption of [Pomanox] could have the potential to modulate satiety indicators.”
Euromed’s press release added, “Interestingly, the consumption of pomegranate extract was associated with a significantly lower amount of food intake during the satiety session compared with the placebo group.”
In the press release, Euromed’s scientific marketing manager, Andrea Zangara, added, “We are very pleased to see these promising results, as they further support the efficacy and safety of Pomanox, expanding its numerous evidence-based health applications to include weight management and behavioral support.”
Reference
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.